Precipio (PRPO, $7) was one of top quarterly gainers, jumping +863.92% to $7 per share. Upon obtaining further approval for expanded use by FDA, phase 2 will broaden our distribution to POC (point-of-care)... Precipio (PRPO, $7) was one of top quarterly gainers, jumping +863.92% to $7 per share. P/E. MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin, EUR/USD, GBP/USD, USD/JPY, AUD/USD, USD/CAD, USD/CHF, Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc, S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index, Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin, US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y. So I opened a long position from... For my record ONLY, this is not financial advice. Buffett Dumps $800M Of Apple, Buys This Instead! nodes[i].dataset.subscription : nodes[i].getAttribute('data-subscription'); if(status ==='true') {nodes[i].checked = true;}}};var nodes = document.querySelectorAll('#form1783 select[data-value]'); if (nodes) { for (var i = 0; i < nodes.length; i++) { var node = nodes[i]; var selectedValue = node.dataset ? Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Completed the internal validation of the FDA-approved COVID-19 serology antibody test in its CLIA laboratory. Simply Wall St. +7.60%. no trading or financial advice. See what's happening in the market right now with MarketBeat's real-time news feed. AT&T Hampered by Setbacks, But Could be a Breakout Play, The Coca-Cola Company (NYSE:KO) Is A Buy For Dividend-Growth Investors, CSX Corporation (NASDAQ:CSX) Is Another Reason To Bet On Transportation, PayPal (NASDAQ: PYPL) Hits All Time Highs And Wants More, The Stars are Aligned for Growth at Align Technology (NASDAQ:ALGN), Workhorse Group (NASDAQ:WKHS) Could Be The Tesla Of Delivery Vehicles, Getting in on AutoNation (NYSE:AN) a Smart Move, 7 Stocks It May Be Time To Take Profits On, 7 Stocks to Buy For the Current Housing Boom, 7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle, 7 Stocks That Could Provide a Year-End Rally, 8 Stocks That Robinhood Investors Got Right, 7 Stocks That Will Help You Forget About the Fed, 7 Stocks That Don’t Care Who Wins the Election, 7 Semiconductor Stocks to Power Your Portfolio, Receive Analysts' Upgrades and Downgrades Daily. Tickeron A.I.dvisor analyzed 384 stocks in the Biotechnology Industry over the last three months, and discovered that 278 of them (72.47%) charted an Uptrend while 106 of them (27.53%) trended down. Precipio, Inc. (NASDAQ:PRPO) issued its quarterly earnings results on Thursday, August, 13th. Fundamental company data provided by Morningstar and Zacks Investment Research. Technical analysis gauges display real-time ratings for the selected timeframes. Precipio, Inc. Common Stock (PRPO) After-Hours Stock Quotes - Nasdaq offers after-hours quotes and extended trading activity data for US and global markets. The strategy must be BOOM and Dump until we see higher highs and higher lows. Waiting confirmation when A-B is crossed. Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Precipio, Inc. is a cancer diagnostics company, which engages in the development and provision of a platform designed to eradicate the problem of misdiagnosis. Learn about financial terms, types of investments, trading strategies and more. The chart below shows up to four years of a company's earnings history. ET). The demand for shares of the company still looks higher than the supply. Precipio had a negative return on equity of 84.96% and a negative net margin of 278.58%. P/E. Please log in to your account or sign up in order to add this asset to your watchlist. Contextual immersion trading strategy idea. If you've got money invested in the market – and especially in popular tech stocks – this is critical information for the days ahead... Start Your Risk-Free Trial Subscription Here, The Diagnosis for Quest Diagnostics: Strong Growth Ahead. Not for a suggestion, Defiantly a risky stock! EPS. First challenge is 1.54 (Closing Price) When autocomplete results are available use up and down arrows to review and enter to select. 326 E 8th St #105, Sioux Falls, SD 57103 | [email protected] | (844) 978-6257 node.dataset.value : node.getAttribute('data-value'); if (selectedValue) { for (var j = 0; j < node.options.length; j++) { if(node.options[j].value === selectedValue) { node.options[j].selected = 'selected';break;}}}}}, Do Not Sell My Personal Information (CA Residents Only). Goal = 0,9750 Precipio & ADS Biotec Launch Seven Beta sites for IV-Cell™, Precipio Launches its Proprietary HemeScreen™ AML (Acute Myeloid Leukemia) Molecular Panel, Precipio Announces a Shareholder Call to Discuss its COVID-19 Progress and Future Plans, Precipio & ADS Biotec Sign Global Distribution Agreement for IV-Cell™, Precipio Announces Q2-2020 Corporate Update Call For Shareholders, Precipio Launches Covid-19 Antibody Test in its CLIA laboratory, Precipio Announces Commercial Launch of COVID-19 Antibody Test, Precipio Announces Q2-2020 Unaudited Pathology Services Revenue Increased Approximately 50% over Q1’20, Precipio Regains Listing Compliance with NASDAQ Minimum Bid Requirement, Precipio Adds Another HemeScreen™ Customer, Q1-2020 Net Revenues increase 77% over Q4-2019 to $1.2M, Precipio Announces Q1-2020 Corporate Update Call For Shareholders, Precipio Launches New HemeScreen™ Reagent Rental Program, Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division, Precipio achieves impressive initial results of Artificial Intelligence Decision-Support Tool, Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership, Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing, Precipio Provides Clarification To Recent S-1 Filing, Precipio announces shareholder update call to kick off 2020, var dom1 = document.querySelector('#form1783 #field1');var field1 = new LiveValidation(dom1, {validMessage: "", onlyOnBlur: false, wait: 300});field1.add(Validate.Presence, {failureMessage:"This field is required"});field1.add(Validate.Format, {pattern: /^([^@\s]+)@((?:[-a-z0-9]+\. The biotechnology company had revenue of $1.31 million for the quarter. © 2020, Nasdaq, Inc. All Rights Reserved. Touch device users, explore by touch or with swipe gestures. The firm that called the Exact Peak of the Dot-Com boom has just issued another major prediction. Not for a suggestion, Defiantly a risky stock! Market Cap. Not advice but thought I'd share. Who Owns Most Of Precipio Inc (NASDAQ:PRPO)? This and other conditions can cause a rise in the share price in the next days. View our full suite of financial calendars and market data tables, all for free. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Precipio last announced its earnings results on August 13th, 2020. Technical analysis A fast and easy way to analyze US Stocks To see all exchange delays and terms of use please see disclaimer. Investors who anticipate trading during these times are strongly advised to use limit orders. Precipio (NASDAQ:PRPO) Earnings Information. May run up until earnings on May 26th. Participation from Market Makers and ECNs is strictly voluntary and as a result, these sessions may offer less liquidity and inferior prices. PRPO NASDAQ. PRPO Up 400% As It Readies For Rollout Of COVID-19 Test, LXRX Realigns Business, VRTX Boosts Outlook - Nasdaq www.nasdaq.com - July 31 at 7:08 AM Precipio up big on launch of COVID-19 blood test - Seeking Alpha The demand for shares of the company looks higher than the supply. The demand for shares of the company still looks higher than the supply. 2.27 - Main Target. PRECIPIO INC NASDAQ. And bought this instead! Is it possible to see returns like $11,012, $13,900 and even an incredible $24,520 from the stock market every single week… With 100% certainty? This and other conditions can cause a rise in the share price in the next days. Its products include MX-ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HRM kits and ICP liquid biopsy testing. Market Cap. Crypto Market Cap, BTC/USD, ETH/USD, USDT/USD, XRP/USD, Bitcoin, EUR/USD, GBP/USD, USD/JPY, AUD/USD, USD/CAD, USD/CHF, Apple, Advanced Micro Devices Inc, Amazon Com Inc, TESLA INC, NETFLIX INC, Facebook Inc, S&P 500, Nasdaq 100, Dow 30, Russell 2000, U.S. Dollar Index, Bitcoin Index, Gold, Silver, Crude Oil, Natural Gas, Corn, Bitcoin, US 10Y, Euro Bund, Germany 10Y, Japan 10Y Yield, UK 10Y, India 10Y. Tickeron A.I.dvisor analyzed 384 stocks in the Biotechnology Industry over the last three months, and discovered that 278 of them (72.47%) charted an Uptrend while 106 of them (27.53%) trended down. document.write(''); View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Cheers. Next is 1.73 (Closing Price) Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Stock prices may also move more quickly in this environment. Chesapeake Energy Corporation (NYSE:CHK) Precipio, Inc. (NASDAQ:PRPO) Precipio, Inc. (NASDAQ:PRPO) closed at $2.3 on the last trading session with an decrease of -1.29%, whereas, it previously closed at $2.33. similar to before the spike? Precipio, Inc., a cancer diagnostics company, provides diagnostic products and services in the United States oncology market. Upcoming Earnings.